Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
MicroRNA binding site polymorphisms as biomarkers in cancer management and research.
Cipollini M, Landi S, Gemignani F. Cipollini M, et al. Pharmgenomics Pers Med. 2014 Jul 23;7:173-91. doi: 10.2147/PGPM.S61693. eCollection 2014. Pharmgenomics Pers Med. 2014. PMID: 25114582 Free PMC article. Review.
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism.
Gemignani F, Neri M, Bottari F, Barale R, Canessa PA, Canzian F, Ceppi M, Spitaleri I, Cipollini M, Ivaldi GP, Mencoboni M, Scaruffi P, Tonini GP, Ugolini D, Mutti L, Bonassi S, Landi S. Gemignani F, et al. Among authors: cipollini m. Mutat Res. 2009 Dec 1;671(1-2):76-83. doi: 10.1016/j.mrfmmm.2009.09.003. Epub 2009 Sep 12. Mutat Res. 2009. PMID: 19751749
Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma.
Cancemi L, Romei C, Bertocchi S, Tarrini G, Spitaleri I, Cipollini M, Landi D, Garritano S, Pellegrini G, Cristaudo A, Pinchera A, Barale R, Elisei R, Landi S, Gemignani F. Cancemi L, et al. Among authors: cipollini m. Int J Cancer. 2011 Dec 15;129(12):2816-24. doi: 10.1002/ijc.25937. Epub 2011 Apr 25. Int J Cancer. 2011. PMID: 21520031
TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.
Cipollini M, Pastor S, Gemignani F, Castell J, Garritano S, Bonotti A, Biarnés J, Figlioli G, Romei C, Marcos R, Cristaudo A, Elisei R, Landi S, Velázquez A. Cipollini M, et al. Int J Cancer. 2013 Dec 15;133(12):2843-51. doi: 10.1002/ijc.28317. Epub 2013 Jul 13. Int J Cancer. 2013. PMID: 23754668
Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24.
Cipollini M, Figlioli G, Garritano S, Bramante S, Maiorano L, Gnudi F, Cecchini A, De Paola F, Damicis L, Frixa T, Landi D, Cancemi L, De Santi C, Melaiu O, Foddis R, Cristaudo A, Bonotti A, Romei C, Elisei R, Pellegrini G, Barale R, Gemignani F, Landi S. Cipollini M, et al. Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2121-5. doi: 10.1158/1055-9965.EPI-13-0790. Epub 2013 Sep 5. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 24008490
Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk.
Figlioli G, Köhler A, Chen B, Elisei R, Romei C, Cipollini M, Cristaudo A, Bambi F, Paolicchi E, Hoffmann P, Herms S, Kalemba M, Kula D, Pastor S, Marcos R, Velázquez A, Jarząb B, Landi S, Hemminki K, Försti A, Gemignani F. Figlioli G, et al. Among authors: cipollini m. J Clin Endocrinol Metab. 2014 Oct;99(10):E2084-92. doi: 10.1210/jc.2014-1734. Epub 2014 Jul 16. J Clin Endocrinol Metab. 2014. PMID: 25029422
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people.
Garritano S, De Santi C, Silvestri R, Melaiu O, Cipollini M, Barone E, Lucchi M, Barale R, Mutti L, Gemignani F, Bonotti A, Foddis R, Cristaudo A, Landi S. Garritano S, et al. Among authors: cipollini m. J Thorac Oncol. 2014 Nov;9(11):1662-8. doi: 10.1097/JTO.0000000000000322. J Thorac Oncol. 2014. PMID: 25436799
Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk.
Figlioli G, Chen B, Elisei R, Romei C, Campo C, Cipollini M, Cristaudo A, Bambi F, Paolicchi E, Hoffmann P, Herms S, Kalemba M, Kula D, Pastor S, Marcos R, Velázquez A, Jarząb B, Landi S, Hemminki K, Gemignani F, Försti A. Figlioli G, et al. Among authors: cipollini m. Sci Rep. 2015 Mar 10;5:8922. doi: 10.1038/srep08922. Sci Rep. 2015. PMID: 25753578 Free PMC article.
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma.
Pellé L, Cipollini M, Tremmel R, Romei C, Figlioli G, Gemignani F, Melaiu O, De Santi C, Barone E, Elisei R, Seiser E, Innocenti F, Zanger UM, Landi S. Pellé L, et al. Among authors: cipollini m. Arch Toxicol. 2016 Dec;90(12):3099-3109. doi: 10.1007/s00204-016-1660-8. Epub 2016 Jan 19. Arch Toxicol. 2016. PMID: 26783003
A Comprehensive Meta-analysis of Case-Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma.
Figlioli G, Elisei R, Romei C, Melaiu O, Cipollini M, Bambi F, Chen B, Köhler A, Cristaudo A, Hemminki K, Gemignani F, Försti A, Landi S. Figlioli G, et al. Among authors: cipollini m. Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):700-13. doi: 10.1158/1055-9965.EPI-15-0652. Epub 2016 Feb 3. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26843521
51 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback